MojiaBio
MojiaBio is a synthetic biology company that produces bio-based polymers (Aliphane®) and Vitamin B5 feed additives (Viridimin®) using its OrthBio® and C1+Bio™ platforms, selling to enterprise customers in coatings, adhesives, automotive, personal care, and animal nutrition.
- Company typePrivate
- Founded2018
- HeadquartersGuangan, China
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What MojiaBio does
MojiaBio (摩珈生物), founded in 2018 and headquartered operationally in Singapore with primary R&D in Shanghai Zhangjiang and a manufacturing site in Sichuan Guang'an, is a synthetic biology company that develops and commercializes bio-based polymers and feed additives produced via fermentation and biocatalysis. Its commercial portfolio centers on two product brands: Aliphane®, a series of bio-based polyurethane and polyurea systems with greater than 70% bio-content used in coatings, adhesives, sealants, and elastomers for automotive, marine, construction, and industrial applications; and Viridimin®, including a Vitamin B5 (calcium pantothenate) product manufactured via a patented ambient-condition bio-process and sold to animal nutrition and food fortification customers. The company also produces bio-based aroma chemicals and is developing C1-based routes to molecules such as 1,3-propanediol (PDO).
The technical backbone comprises two proprietary platforms. OrthBio® decouples biomass conversion from target product synthesis, enabling parallel product development and reducing capital intensity, energy use, and development cycles relative to traditional fermentation. C1+Bio™ (also referenced as Cn+Bio™) is a new-to-nature metabolic pathway that converts non-food C1 feedstocks—methanol, formic acid, and CO2—into high-value chemicals, providing feedstock optionality and a claimed greater than 60% carbon footprint reduction versus petrochemical incumbents. The FORCE (Formyl-CoA FORance Extension) reaction underpins this chemistry. Operations are supported by an in-house manufacturing facility in Guang'an (using AIoT smart energy management), a near-100-person joint research team at the Xianghu Laboratory in Hangzhou, and an R&D presence in Singapore (including the SGD 44.8M SBTP platform with A*STAR and NUS) and Florida, USA.
MojiaBio sells directly to enterprise customers in target verticals through a B2B field-sales motion focused on co-development with "leading global brands." Revenue is generated through product sales rather than licensing or royalties, with pricing not publicly disclosed. The company has raised approximately $80M in a June 2022 Series B led by Temasek, with prior backing from Asia Green Fund, Bits x Bites, LYZZ Capital, Sento Investment, and Green Capital. No disclosed revenue, ARR, or GMV figures are available in the source material.
MojiaBio firmographics
Firmographics- Name
- MojiaBio
- Legal name
- MOJIABIO
- Website
- https://mojiabio.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MojiaBio is a synthetic biology company that produces bio-based polymers (Aliphane®) and Vitamin B5 feed additives (Viridimin®) using its OrthBio® and C1+Bio™ platforms, selling to enterprise customers in coatings, adhesives, automotive, personal care, and animal nutrition.
- Ownership category
- akta.pro rank
MojiaBio industry classification
Industry- Product category
- Bio-based Specialty Chemicals
- NAICS
- Resin and Synthetic Rubber Manufacturing (32521), Cyclic Crude, Intermediate, and Gum and Wood Chemical Manufacturing (325194), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Industrial Organic Chemicals (2860), Adhesives & Sealants (2891), Food And Kindred Products (2000)
- akta.pro primary industry
- Bio-based Resins, Adhesives, Coatings & Sealants (EUAAAIAG)
- akta.pro secondary industries
- Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids) (IMAMALAB), Bio-based Solvents & Process Chemicals (e.g., bio-acetone, bio-butanol, bio-IPA, green solvents) (EUAAAIAB)
Keywords
Where MojiaBio is headquartered
LocationHeadquarters
- HQ city
- Guangan
- HQ country
- China
- HQ region
- Asia
Offices6 records
Markets served
MojiaBio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D
Revenue model
- Bio-based Materials Sales: Sale of Aliphane® series bio-based polymer products (polyurethane/polyurea systems) for coatings, adhesives, sealants, elastomers. Sold directly to manufacturers in automotive, industrial, marine, construction, and other sectors.
- Feed Additives Sales: Sale of Viridimin® B5 (Vitamin B5) as animal feed additive and food fortification ingredient. Distributed to animal nutrition and food processing companies.
- Aroma & Care Products: Sale of bio-based aroma chemicals produced through synthetic biology and green chemistry conversion of biomass (glucose, glycerol, dipentene) into high-value, low-carbon fragrance and flavor products.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
MojiaBio product offering
Product offeringCore offering
MojiaBio manufactures and sells bio-based chemical products produced through synthetic biology and proprietary biomanufacturing platforms. Its commercial offerings include the Aliphane® series of bio-based polyurethane and polyurea polymers for use in coatings, adhesives, sealants, and elastomers, and Viridimin® (including Vitamin B5) feed and food fortification additives. These products are enabled by two proprietary technology platforms — OrthBio® for decoupling biomass conversion from product synthesis, and C1+Bio™ for converting non-food C1 feedstocks such as methanol and CO2 into target chemicals.
Product overview
MojiaBio is a biomanufacturing company offering a portfolio of products centered on two main brands: Aliphane® (bio-based polymer materials for coatings, adhesives, sealants, and elastomers) and Viridimin® (feed additives including Vitamin B5). These products are enabled by two proprietary technology platforms: OrthBio® (a parallel architecture that decouples biomass conversion from product synthesis for faster development cycles) and C1+Bio™ (a new-to-nature metabolic pathway utilizing C1 carbon sources like methanol for cost-efficient production). The company also operates a Sustainable Biomanufacturing Technology Platform (SBTP) developed with A*STAR for producing bio-based molecules including 1,3-propanediol (PDO).
Differentiator
Problem solved
Functional benefit
Brands
- Viridimin®: Brand of animal feed additives including Vitamin B5, produced using a gentle biological method that eliminates high-temperature and high-pressure processes.
- Aliphane®
- OrthBio®
- Cn+Bio™
Products and services
- Aliphane® Bio-based Polymer Products Series of bio-based polyurethane/polyurea systems offering high bio-content (>70%) with excellent UV and chemical resistance and a wide processing window. Sold to manufacturers of coatings, adhesives, sealants, and elastomers serving automotive, industrial, marine, construction, renewable energy, footwear, 3D printing, and textile applications as a sustainable alternative to petroleum-based polyurethanes.
- Viridimin® B5 (Vitamin B5) Vitamin B5 (D-pantothenic acid) produced via a patented biological process that operates under ambient conditions, eliminating the high-temperature, high-pressure steps used in traditional chemical production. Sold as an essential nutrient additive for animal feed premixes and as a food fortification ingredient for cereals, bread, and dairy products.
- Sustainable Biomanufacturing Technology Platform (SBTP) Sustainable biomanufacturing technology platform developed with A*STAR and partners (NUS, A*STAR ISCE2/SIFBI) that integrates synthetic biology, enzyme engineering, computational modeling, and bioprocessing to produce bio-based molecules such as 1,3-propanediol (PDO) for use in textiles, automotive, personal care, coatings, and biodegradable plastics.
Quantifiable outcome
- Over 7 million barrels of oil reduction per year from 400 KT Aliphane® production
- +6 more outcomes
Companies that use MojiaBio
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
MojiaBio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature5 records
MojiaBio partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core, supporting and major.
- Xianghu Laboratory (湘湖实验室)coreJoint Synthetic Biology Innovation Center established in Hangzhou with thousands of square meters of laboratory space. Nearly 100-person research team led by Dr. Ramon Gonzalez focusing on amino acid green manufacturing, plant functional ingredients, chassis cell technology upgrades, new bio-based materials development, food security solutions, and collaborative areas.
- A*STAR (Agency for Science, Technology and Research)coreSGD 44.8 million collaboration to develop Sustainable Biomanufacturing Technology Platform (SBTP) integrating advanced synthetic biology and bioprocessing innovations. A*STAR SIFBI provides enzyme engineering expertise for faster, more reliable, higher-yield conversion. Platform aims to produce bio-based molecules like 1,3-propanediol (PDO) cost-competitive with conventional processes using methanol and ethylene glycol.
- A*STAR Institute of Sustainability for Chemicals, Energy and Environment (ISCE2)coreProvides synthetic biology and enzyme engineering capabilities for the SBTP collaboration
- National University of Singapore (NUS)supportingProvides computational modeling expertise to engineer enzymes and microbial strains for the SBTP platform
- Hunan Haili (湖南海利)majorStrategic cooperation agreement for R&D and industrialization collaboration to jointly promote the prosperity and development of the biomanufacturing industry.
- Dongfang Low Carbon (东方低碳)supportingConnected through shareholder Asia Green Fund. Provides energy-saving and emission-reduction service solutions for company's Guang'an factory, implementing AIoT smart energy management platform and waste heat recovery projects.
Scale indicators10 records
Recent moves10 records
Expansion highlights6 records
MojiaBio competitors and assessment
Company assessmentDirect peers
- Genomatica: Genomatica develops bio-based process technologies for widely-used chemicals (e.g., bio-BDO, bio-butylene glycol) via engineered microbes. Direct peer on bio-based platform chemicals targeting industrial-scale substitution of petrochemical inputs.
- Carbios: Carbios develops enzymatic recycling and bio-based monomer technologies (e.g., bio-PEF, bio-MBH) for plastics and polymers. Comparable technology approach (biocatalysis for polymer feedstocks) and end-markets (coatings, packaging polymers).
- Amyris: Amyris pioneered synthetic biology for specialty ingredients (squalane, fragrances, sweeteners) using engineered yeast. Comparable technology and product focus on bio-based aroma/specialty chemicals, though illustrates execution and capital risks in the category.
- Conagen: Conagen is a US-based synthetic biology firm producing high-value ingredients (vitamins, flavors, amino acids) via fermentation. Closely comparable to MojiaBio on technology (precision fermentation) and end-markets (Vitamin B5, aroma chemicals); Dr. Gonzalez also serves on its advisory board.
- Cathay Biotech: Cathay Biotech is a leading Chinese bio-manufacturer of long-chain bio-based polyamides (e.g., bio-pentanediamine) used in coatings, adhesives, and engineering plastics. Directly comparable to MojiaBio on bio-based polymer platform targeting same downstream coatings and automotive customers in China.
- LanzaTech: LanzaTech is a synthetic biology company that gasifies waste gases (CO, CO2) into fuels and chemicals using proprietary carbon-fixing microbes. Direct overlap with MojiaBio's C1+Bio™ non-food feedstock thesis and Dr. Gonzalez serves on its advisory board, signaling comparable technology positioning.
Broad incumbents
- Ginkgo Bioworks: Ginkgo Bioworks operates a large-scale synthetic biology platform serving multiple end-markets including specialty chemicals, flavors, and industrial enzymes. Broader and more diversified than MojiaBio but competes for similar industrial bio-manufacturing customers and talent.
- CJ CheilJedang / CJ BIO: CJ CheilJedang is a large Korean fermentation producer of amino acids, nucleotides, and bio-based specialty ingredients including Vitamin B5. Comparable to MojiaBio on bio-based feed additives and platform fermentation technology at industrial scale.
- DuPont Tate & Lyle Bio Products: Joint venture producing bio-based 1,3-propanediol (Bio-PDO™) from corn sugar for cosmetics, personal care, and polymers. Incumbent in the bio-PDO category that MojiaBio's SBTP platform is targeting as a new entrant.
Emerging players
- Bloom Biorenewables: Bloom Biorenewables develops bio-based alternatives to fossil-derived polymers (e.g., furan-based resins) for coatings, adhesives, and composites. Emerging peer with direct overlap on bio-based polymer platform targeting the same coatings/adhesives end-markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
MojiaBio social profiles
Digital presenceMojiaBio financial estimates
Financial estimateRevenue estimate
Valuation estimate
MojiaBio leadership team
Management profileNumber of profiles
Profiles5 records
MojiaBio subsidiaries and ownership
Company hierarchySubsidiaries3 records
MojiaBio funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MojiaBio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MojiaBio
What does MojiaBio do?
MojiaBio manufactures and sells bio-based chemical products produced through synthetic biology and proprietary biomanufacturing platforms. Its commercial offerings include the Aliphane® series of bio-based polyurethane and polyurea polymers for use in coatings, adhesives, sealants, and elastomers, and Viridimin® (including Vitamin B5) feed and food fortification additives. These products are enabled by two proprietary technology platforms — OrthBio® for decoupling biomass conversion from product synthesis, and C1+Bio™ for converting non-food C1 feedstocks such as methanol and CO2 into target chemicals.
Is MojiaBio a public or private company?
MojiaBio is a private company. It is classified as venture growth investor backed and is currently operating.
When was MojiaBio founded?
MojiaBio was founded in 2018. It employs 11 to 50 people.
Where is MojiaBio based?
MojiaBio is headquartered in Guangan, China, in the Asia region.
How does MojiaBio make money?
Three revenue lines are on record. Bio-based Materials Sales are the primary driver. The others are feed Additives Sales and aroma & Care Products.
Who are MojiaBio's main competitors?
Direct peers on record are Genomatica, Carbios, Amyris, Conagen, Cathay Biotech and LanzaTech. Broad incumbents are Ginkgo Bioworks, CJ CheilJedang / CJ BIO and DuPont Tate & Lyle Bio Products. Bloom Biorenewables is listed as an emerging player.
Does MojiaBio have an API?
No public API is recorded for MojiaBio.
What industry is MojiaBio in?
MojiaBio's product category is Bio-based Specialty Chemicals. Its primary akta.pro industry code is EUAAAIAG, Bio-based Resins, Adhesives, Coatings & Sealants, with a secondary code of IMAMALAB, Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids). Its NAICS code is 32521 and its SIC code is 2860.